| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |